5-(Methylsulfonyl)-1H-indole → HCID 67615520, compound
Reaction equation
[CH3:1][S:2]([C:5]1[CH:6]=[C:7]2[C:11](=[CH:12][CH:13]=1)[NH:10][CH:9]=[CH:8]2)(=[O:4])=[O:3].Br[C:15]1[N:16]=[C:17]([O:20][CH2:21][CH:22]2[CH2:27][CH2:26][N:25]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:24][CH2:23]2)[S:18][CH:19]=1>>[C:31]([O:30][C:28]([N:25]1[CH2:24][CH2:23][CH:22]([CH2:21][O:20][C:17]2[S:18][CH:19]=[C:15]([N:10]3[C:11]4[C:7](=[CH:6][C:5]([S:2]([CH3:1])(=[O:4])=[O:3])=[CH:13][CH:12]=4)[CH:8]=[CH:9]3)[N:16]=2)[CH2:27][CH2:26]1)=[O:29])([CH3:34])([CH3:32])[CH3:33]Participants
3
Procedure
The title compound was prepared by following the similar procedure as described in Example-1 by using 5-(methylsulfonyl)-1H-indole (intermediate-21) and tert-Butyl 4-(((4-bromothiazol-2-yl)oxy)methyl)piperidine-1-carboxylate (intermediate 47) (0.013 g, 10%).
Sources & evidence
- ORD record
- ord-c602af78f9534ad68d1a9a20ecdfe3a7
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09000175B2
Reaction notes
Loading…